Blood And Blood Components in Depth Study and Huge Demand In Future 2024-2031: Becton, Dickinson & Co., Kidde-Fenwal Inc.

Market Overview:

Blood and blood components include whole blood, red blood cells, platelets, plasma, cryoprecipitate, and stem cells that are collected from human blood and provided for transfusion or further therapeutic purposes. They are used in treatment of blood disorders, cancer, surgeries, and injuries.

Market Dynamics:

The blood and blood components market is expected to grow significantly during the forecast period owing to the increased demand for blood transfusions. According to the World Health Organization, over 100 million blood donations are collected globally each year from voluntary unpaid donors for transfusion purposes. Moreover, rising burden of blood disorders such as anemia, leukemia, and hemophilia is also fueling the demand for blood and blood components across the globe. The market is also driven by increasing number of surgeries performed annually that require blood transfusions. Various hematology societies and non-profit organizations are raising awareness about importance of blood donations, which is further propelling the market growth.

Request a Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/4574

Top Companies Covered In This Report: Becton, Dickinson & Co., Kidde-Fenwal Inc., Bio-Rad Laboratories, Inc., Cerus Corporation, Immucor, Beckman Coulter, Inc., bioMérieux SA, Octapharma AG, Abbott, CSL Behring LLC, MacoPharma, Shanghai RAAS, China Biologic Products Holdings, Inc., Takeda Pharmaceutical Company Limited, Grifols S.A., Bharat Serums and Vaccines Ltd., and Terumo BCT Inc.

Market Segmentation:

By Product Type: Whole Blood, Blood Components (Red Blood Cells, White Blood Cells, Platelets, Plasma)

By Application: Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders, Others (Others include rare blood diseases)

By End User: Hospitals, Ambulatory Surgical Centers, Blood and Blood Component Bank, Others

Geographically, the detailed analysis of consumption, revenue, Blood And Blood Components Market share, growth rate, etc. of the following regions:

» North America (United States, Canada, and Mexico)
» Europe (Germany, France, UK, Russia, Italy)
» Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
» Latin America (Brazil, Argentina, Colombia)
» Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

INCREASE IN THE NUMBER OF ACCIDENTS AND TRAUMA CASES IS A KEY DRIVER FOR THE BLOOD AND BLOOD COMPONENTS MARKET

One of the major drivers fueling the growth of the blood and blood components market is the rising number of accidents and trauma cases across the globe. Road accidents are a major public health issue and have remained the second leading cause of death among people aged between 5 to 29 years, according to the World Health Organization (WHO). The high rate of accidents exposes the need for whole blood or packed red blood cells, platelets, fresh frozen plasma, cryoprecipitate, and other blood components for emergency medical assistance and lifesaving transfusions. In 2020 alone, India witnessed nearly 1.5 lakh road accident deaths as per government data. Such incidents reinforce the demand for donated or banked blood especially in developing nations with limited medical infrastructure.

UPTICK IN BLOOD DONATIONS AND BLOOD COLLECTION DRIVES IS BOOSTING MARKET GROWTH

Another key driver for the blood and blood components market is the steady increase in awareness campaigns focusing on regular blood donations. This has translated to higher engagement of voluntary blood donors worldwide. For instance, the annual blood donation campaigns by nonprofit organizations in countries like the US collects over 21 million blood donations every year. Similarly, in India initiatives like 'India Bleeds' and 'My First Blood Donation' by various NGOs and hospitals have bolstered donations over the past decade. Furthermore, several companies and educational institutions regularly organize on-campus blood collection drives to meet community needs and promote the donation process as a civic duty. This positive trend of high donation rates ensures continuous supply of blood and its components to healthcare facilities.

Direct Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4574

STRINGENT REGULATIONS FOR IMPORT OF BLOOD AND DERIVATIVES IS A KEY RESTRAIN

One of the major challenges faced by the blood and blood components market is the stringent regulations pertaining to the import of blood, plasma fractions, and cell therapy derivatives across regions. Each nation or economic bloc has developed their own set of guidelines and certifications that importers must comply with in order to sell their products in those territories. For instance, the European Union has introduced a 'Safety Features' directive that enforce unique identifiers on the labels of all blood-related goods from third countries before they can be sold within the EU. Similarly, the US Food and Drug Administration (FDA) subjects imports of HCT/Ps (human cells, tissues, and cellular and tissue-based products) to pre-market approval pathways that require comprehensive documentation and multiple rounds of evaluation, delaying their availability. Such trade barriers negatively impact the easy flow of components and derivative products globally.

GROWTH OF RECOMBINANT BLOOD PRODUCTS OFFERS LUCRATIVE OPPORTUNITIES

The emergence of novel recombinant blood products using cutting-edge biotechnology techniques provides lucrative opportunities for established as well as new entrants in the global blood and blood components marketplace. Recombinant coagulation factors like Factor VIII used for hemophilia treatments have already established themselves as reliable alternatives to plasma-derived versions, while recombinant albumin saw rising preference amid the COVID-19 pandemic. Novel therapies in clinical testing include hyperimmune globulins produced in the milk of transgenic animals for specific conditions, an artificial erthyropoietin injected to stimulate red cell production in anemic cancer patients, and genetically-engineered antibody fragments or fusion proteins to treat bleeding disorders. Backed by their improved safety profile and cost-effectiveness, such recombinant agents are poised to capture a substantial market share and drive future revenues.

INNOVATIONS IN BLOOD SEPARATION TECHNOLOGY WILL SHAPE MARKET TRENDS

A noteworthy trend influencing the dynamics of the blood and blood components market involves ongoing innovations in blood separation technology. Conventional blood component separators relied on centrifugation to divide whole blood into its derivatives. However, separation systems now employ advanced microfluidics techniques and automated instrumentation to achieve high-purity fractions at a large-volume and rapid scale suitable for real-world healthcare settings. Emerging cell therapy manufacturing platforms are especially equipped with acoustophoresis, dielectrophoresis or magnetophoresis separation capabilities useful for concentrating stem cells or immune cells from patient blood. Continuous flow centrifugation devices

Reason to Buy Our Market Research Report:

- Enhance your decision-making capability in a more rapid and time-sensitive manner.
- Identify key growth and investment opportunities in the Thrombolytic Therapy market.
- Facilitate decision-making based on strong historic and forecast data for the Thrombolytic Therapy market.
- Position yourself to gain the maximum advantage of the industry's growth potential.
- Identify key partners and business development avenues.
- Understand and respond to your competitors' business structure, strategy, and prospects

𝐅𝐀𝐐'𝐬

Q.1 What are the main factors influencing the Blood And Blood Components market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market's opportunities, risks, and general structure?
Q.4 Which of the top Blood And Blood Components Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Blood And Blood Components market's distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area's assessment of agreements, income, and value implicate?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/4574

Contact Us:

Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞Phone: U.S.: +1-206-701-6702
📞U.K.: +44-020-8133-4027
📞JAPAN: +81-50-5539-1737
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.